ERbeta-selektive agonists: Innovative therapy for treatment of cholangiocarcinoma

Reference number
Coordinator Karo Bio Aktiebolag
Funding from Vinnova SEK 75 000
Project duration January 2010 - April 2010
Status Completed

Last updated 25 November 2019

Reference number 2010-00872

Page statistics